Influence of Anti-VEGF Injections on Longitudinal Changes in Vascular Metrics Measured by OCTA in Age Related Macular Degeneration: A Retrospective Real-World Study. [PDF]
Zhu Y +17 more
europepmc +1 more source
When Effective Therapies Collide: Aorto-Esophageal Fistula After Thoracic Radiotherapy and Anti-VEGF TKI in a Long-Survivor with mRCC. [PDF]
Rota S +5 more
europepmc +1 more source
Psychosocial determinants of anti-VEGF treatment adherence in AMD patients: optimization of one-stop intravitreal injection service model. [PDF]
Zhang X +7 more
europepmc +1 more source
Visual acuity and retinal thickness outcomes following anti-VEGF therapy in RVO: influence of early vs. delayed treatment. [PDF]
Chung L, Staniszewski B, Johnstone P.
europepmc +1 more source
Nationwide trends and regional variation in intravitreal injections and anti-VEGF agent use in Japan from 2017 to 2022: An analysis of the NDB Open Data. [PDF]
Kabata Y, Terauchi R, Nakano T.
europepmc +1 more source
Efficacy and safety of intravitreal anti-VEGF for myopic choroidal neovascularization. [PDF]
Liu JY, Liu JP, Li XR.
europepmc +1 more source
Measurement of Acute Intraocular Pressure Elevation Immediately After Intravitreal Anti-VEGF Injection and Analysis of Prefilled Syringe Accuracy. [PDF]
Itoh K, Negishi M.
europepmc +1 more source
Epigenetic modulation of BARD1 to enhance anti-VEGF therapy. [PDF]
Bayraktar E +28 more
europepmc +1 more source
COMPARE COMBINED USE OF ANTI-VEGF DRUGS DURING OR AFTER PARS PLANA VITRECTOMY FOR DIABETIC MACULAR EDEMA GUIDED BY MICROSCOPE-INTEGRATED OPTICAL COHERENCE TOMOGRAPHY. [PDF]
Zhu J, Liu J, Chen YX, Yang XW, Zhu RR.
europepmc +1 more source
Short-term real-world outcomes of switching to faricimab in anti-VEGF-refractory retinal vein occlusion: a prospective study. [PDF]
Kilani A +6 more
europepmc +1 more source

